Clinical Trial Update: Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating radiation therapy with or without temozolomide in women with brain metastases from breast cancer; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Institut Curie | Conditions: Breast Cancer, Metastatic Cancer | Phase 2 | Status: UNKNOWN